about
Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancersBiomarkers in nonalcoholic fatty liver diseaseLipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes.Impaired liver function in Xenopus tropicalis exposed to benzo[a]pyrene: transcriptomic and metabolic evidenceOxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.USF-1 genetic polymorphisms confer a high risk of nonalcoholic fatty liver disease in Chinese population.SteatoNet: the first integrated human metabolic model with multi-layered regulation to investigate liver-associated pathologies.Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer.Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver diseaseThe role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).Experimental models of liver fibrosisNovel hepatic microRNAs upregulated in human nonalcoholic fatty liver diseaseGenetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD.Mitochondrial-related proteomic changes during obesity and fasting in mice are greater in the liver than skeletal muscles.Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity.Paediatric non-alcoholic fatty liver disease: an overview.Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.(-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis related genes in non-alcoholic fatty liver disease.Systems-level organization of non-alcoholic fatty liver disease progression network.Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver disease.Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice.Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice.Nonalcoholic fatty liver disease: Evolving paradigms.Genome-Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic Boys.The in vivo antineoplastic and therapeutic efficacy of troxerutin on rat preneoplastic liver: biochemical, histological and cellular aspects.Unexpected metabolic disorders induced by endocrine disruptors in Xenopus tropicalis provide new lead for understanding amphibian decline.Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment.
P2860
Q27004276-B207E77A-733F-414E-8410-5A7A385EDE39Q28080541-74BBB7E8-9F4A-4BB1-BA90-13341963FB2CQ33569937-CAF8BA1B-DD19-4B5B-8FE3-ECB8CCDE4C8DQ34076651-AF23E896-7AB3-4B80-94D8-73A4AFC2DC3AQ35183888-3FE9A8BE-ADF0-4183-8192-DBCF3E58627EQ35480721-69C59714-2945-436A-8A06-544ED0DC563AQ35513572-AD9AE384-C265-4A7D-ADD1-A7AFC4A50A35Q35581153-737F5BB4-6DA4-4CD9-8080-EE070D3299D6Q36083434-92EE78AB-A13C-4B0B-9834-BBC3AD88E5E4Q36123336-304D6E90-2B17-4D61-8F67-C56AE6F76798Q36442525-2042AC90-32D6-4B5B-8C17-292FFEAA7976Q36597717-037CE4A4-697E-4531-9E25-E86FA1040BBFQ37146192-CE9D2F5D-5B5A-4C86-9023-8073DF6C9A0FQ37420964-B0C7815E-7E4D-462F-821A-0DAD495A9697Q37670352-4C0BC2C3-AC02-4A8F-9C78-BE558ECE8C9EQ38197690-3453C60B-4646-4E54-A16E-659E0B686A3BQ38370919-67CC1641-670B-4544-85EF-1D3D8949F505Q38430909-D852DEE4-E4C0-46C4-8D9A-D34D90098E85Q38620897-38DC4AEE-5DB8-4107-8D63-D9669DBFB11FQ38660731-221F5561-EDF9-481C-9891-0CEDF61ABB9DQ38845334-283F5941-31CC-4F92-86B5-CFB8736B4412Q41361264-3711E379-D2C2-4548-85EC-1F512E8039C0Q42033362-0D761BF0-D144-471C-AFD5-EFC8ADF5C82BQ42695154-8DF04773-10AB-4889-BB90-5CC2D30B935EQ46617785-CB0BCAAF-1C56-4BC8-B5C3-FD257780929DQ51217468-73423487-F03E-420F-B779-151C28714744Q52568660-03937D59-328F-4D8C-A50C-0376B57A153EQ53752831-64B44BC7-6A56-4FD1-AD8D-AF59BEF18AC3Q55323878-EF6FDEF2-B7BF-4013-98A0-27B515237BDB
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genomic aspects of NAFLD pathogenesis.
@en
type
label
Genomic aspects of NAFLD pathogenesis.
@en
prefLabel
Genomic aspects of NAFLD pathogenesis.
@en
P1433
P1476
Genomic aspects of NAFLD pathogenesis
@en
P2093
Adviti Naik
P356
10.1016/J.YGENO.2013.03.007
P577
2013-03-29T00:00:00Z